Related Experiment Video

Updated: Jun 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Strategies of treatment of pediatric hypertension

Mouin G Seikaly1, Sawsan Bahlawan-Seikaly

  • 1Division of Pediatric Nephrology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75235-9063, USA. mouin.seikaly@childrens.com

Le Journal Medical Libanais. the Lebanese Medical Journal
|April 6, 2011
PubMed

Insights

Pediatric hypertension, a risk factor for adult hypertension, is increasingly recognized by healthcare providers. Early intervention may improve long-term outcomes, though research is ongoing.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Childhood hypertension is a significant predictor of adult hypertension and associated cardiovascular risks.
  • Conceptual understanding among pediatric health care providers has evolved over the past two decades.
  • Early therapeutic interventions are believed to favorably influence long-term hypertension outcomes.

Purpose of the Study:

  • To review current understanding and management of childhood hypertension.
  • To discuss the unique aspects of hypertension in children compared to adults.
  • To explore newer pharmacological treatments for pediatric hypertension.

Main Methods:

  • Literature review of studies on childhood hypertension.
  • Analysis of conceptual shifts in healthcare provider attitudes.
  • Discussion of current treatment guidelines and emerging therapies.

Main Results:

  • Childhood hypertension poses a substantial risk for future cardiovascular disease.
  • There is a consensus on the potential benefits of early treatment.
  • Several key questions regarding childhood hypertension remain understudied and debated.

Conclusions:

  • Pediatric hypertension requires focused attention due to its long-term implications.
  • Further research is essential to address existing controversies and optimize treatment strategies.
  • Novel pharmacological agents offer new possibilities for managing hypertension in children.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...